Diabetes duration and advanced diabetes-related complications in lower-extremity versus coronary revascularization

Clicks: 11
ID: 329947
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #289 of 409 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 409 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
CONTEXT: Diabetes-related burden, including longer diabetes duration and advanced complications, substantially influences management strategies and healthcare utilization among patients with diabetes. It remains unclear whether the diabetes-related burden is comparable between patients with lower extremity artery disease (LEAD) and those with coronary artery disease (CAD), which are commonly grouped as manifestations of cardiovascular disease. OBJECTIVE: This study aimed to compare diabetes-related burden between patients with diabetes undergoing revascularization for LEAD and those undergoing revascularization for CAD. METHODS: This cross-sectional study analyzed 5,808 patients with diabetes undergoing revascularization for LEAD or CAD, who were registered in a prospective multicenter study. Diabetes duration, glycated hemoglobin levels, and the presence of advanced diabetes-related complications were assessed at the time of index revascularization and compared cross-sectionally between the LEAD and CAD groups. RESULTS: The LEAD group exhibited a longer diabetes duration and a higher prevalence of advanced complications, whereas glycated hemoglobin levels at revascularization did not significantly differ between the groups. The prevalence of advanced complications remained higher in the LEAD group after adjustment for diabetes duration. The adjusted prevalence ratios of LEAD relative to CAD were 1.57 (95% confidence interval, 1.41-1.75, P < 0.001) for proliferative retinopathy, 2.39 (1.82-3.13, P < 0.001) for loss of protective sensation, and 2.12 (1.82-3.13, P <0.001) for dialysis-dependent renal failure, respectively. CONCLUSIONS: Patients undergoing revascularization for LEAD exhibited a longer diabetes duration than those undergoing revascularization for CAD. They also had a higher prevalence of advanced diabetes-related complications, even after adjustment for diabetes duration.
Reference Key
openalex_W7214380043 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mitsuyoshi Takahara, Yoshimitsu Soga, Osamu Iida
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag387
URL
https://doi.org/10.1210/clinem/dgag387
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.